MG
VRTX icon

McHugh Group’s Vertex Pharmaceuticals VRTX Stock Holding History

McHugh Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$261K Hold
500
– – 0.13% 74
2026
Q2 		$248K Hold
500
– – 0.13% 78
2026
Q1 		$223K Hold
500
– – 0.13% 75
2025
Q4 		$227K Buy
+500
New +$216K 0.13% 74
2025
Q3 		– Sell
-500
Closed -$223K – 81
2025
Q2 		$223K Hold
500
– – 0.15% 62
2025
Q1 		$242K Hold
500
– – 0.18% 54
2024
Q4 		$201K Buy
+500
New +$232K 0.15% 67

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

McHugh Group's VRTX Position: Q3 2026 in Review

McHugh Group held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 500 shares worth $261K. The position accounts for 0.13% of the portfolio, ranked #74.

McHugh Group first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 700 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • McHugh Group held 500 shares of Vertex Pharmaceuticals worth $261K as of Q3 2026.
  • McHugh Group left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.13% of McHugh Group's portfolio in Q3 2026, its #74 holding.
  • McHugh Group first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 700 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on McHugh Group's 13F filing for Q3 2026, filed 19 Oct 2026.